Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia
Shih-Han Lee,
Irtisha Singh,
Sarah Tisdale,
Omar Abdel-Wahab,
Christina S. Leslie and
Christine Mayr ()
Additional contact information
Shih-Han Lee: Memorial Sloan Kettering Cancer Center
Irtisha Singh: Memorial Sloan Kettering Cancer Center
Sarah Tisdale: Memorial Sloan Kettering Cancer Center
Omar Abdel-Wahab: Memorial Sloan Kettering Cancer Center
Christina S. Leslie: Memorial Sloan Kettering Cancer Center
Christine Mayr: Memorial Sloan Kettering Cancer Center
Nature, 2018, vol. 561, issue 7721, 127-131
Abstract:
Abstract DNA mutations are known cancer drivers. Here we investigated whether mRNA events that are upregulated in cancer can functionally mimic the outcome of genetic alterations. RNA sequencing or 3′-end sequencing techniques were applied to normal and malignant B cells from 59 patients with chronic lymphocytic leukaemia (CLL)1–3. We discovered widespread upregulation of truncated mRNAs and proteins in primary CLL cells that were not generated by genetic alterations but instead occurred by intronic polyadenylation. Truncated mRNAs caused by intronic polyadenylation were recurrent (n = 330) and predominantly affected genes with tumour-suppressive functions. The truncated proteins generated by intronic polyadenylation often lack the tumour-suppressive functions of the corresponding full-length proteins (such as DICER and FOXN3), and several even acted in an oncogenic manner (such as CARD11, MGA and CHST11). In CLL, the inactivation of tumour-suppressor genes by aberrant mRNA processing is substantially more prevalent than the functional loss of such genes through genetic events. We further identified new candidate tumour-suppressor genes that are inactivated by intronic polyadenylation in leukaemia and by truncating DNA mutations in solid tumours4,5. These genes are understudied in cancer, as their overall mutation rates are lower than those of well-known tumour-suppressor genes. Our findings show the need to go beyond genomic analyses in cancer diagnostics, as mRNA events that are silent at the DNA level are widespread contributors to cancer pathogenesis through the inactivation of tumour-suppressor genes.
Keywords: Intronic Polyadenylation (IPA); Tumour-suppressor Gene (TSGs); Effect mRNA; Mecium Cells; Retained Amino Acids (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (5)
Downloads: (external link)
https://www.nature.com/articles/s41586-018-0465-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:561:y:2018:i:7721:d:10.1038_s41586-018-0465-8
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-018-0465-8
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().